NASDAQ:DNAC Social Capital Suvretta Holdings Corp. III (DNAC) Stock Price, News & Analysis → AI “wealth window” is closing soon! (From Paradigm Press) (Ad) Free DNAC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$9.25▼$10.5050-Day Range$8.41▼$10.0052-Week Range$8.03▼$10.55Volume8,160 shsAverage Volume178,857 shsMarket Capitalization$237.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Social Capital Suvretta Holdings Corp. III alerts: Email Address Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. About Social Capital Suvretta Holdings Corp. IIISocial Capital Suvretta Holdings Corp. III does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on searching for a target business operating in the biotechnology industry and within the organ space sub-sector. Social Capital Suvretta Holdings Corp. III was incorporated in 2021 and is based in Henderson, Nevada.Read More Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. DNAC Stock News HeadlinesFebruary 10, 2024 | finance.yahoo.comBooz Allen Hamilton Holding Corporation (BAH)December 12, 2023 | markets.businessinsider.comCGrowth Capital Inc. Bolsters Mining Division with Team Expansion and Expert AppointmentsApril 18, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.November 16, 2023 | markets.businessinsider.comCGrowth Capital Secures $1 Million in Non-Debt FinancingNovember 1, 2023 | investing.comOji Holdings Corp. (3861)October 24, 2023 | investing.comKuriyama Holdings Corp (3355)July 22, 2023 | wsj.comLeader Capital Holdings Corp.April 5, 2023 | morningstar.comSocial Capital Suvretta Holdings Corp II Class AApril 18, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.January 24, 2023 | seekingalpha.comBREZ Breeze Holdings Acquisition Corp.December 23, 2022 | morningstar.comSocial Capital Suvretta Holdings Corp II Class A DNAB Stock QuoteDecember 8, 2022 | bloomberg.comCredit Suisse Raises $4.3 Billion Capital for RestructuringNovember 28, 2022 | reuters.comFerrotec Holdings CorpJuly 15, 2022 | finance.yahoo.comWinston-Salem regenerative medicine company ProKidney goes public through $600M merger with 'SPAC King'July 13, 2022 | bizjournals.comWinston-Salem regenerative medicine company ProKindey goes public through $600M merger with 'SPAC King'July 12, 2022 | seekingalpha.comProKidney goes public through merger with SPAC Social Capital Suvretta, stock slides 7%July 12, 2022 | finance.yahoo.comRevolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. IIIJuly 8, 2022 | finance.yahoo.comSocial Capital Suvretta Holdings Corp. III Announces Reconvened Extraordinary General Meeting of ShareholdersJuly 7, 2022 | seekingalpha.comSPAC Social Capital Suvretta III delays shareholder vote on ProKidney mergerJune 23, 2022 | finance.yahoo.comProKidney Corroborates the Mechanism of Action of REACT™ with Cell Marker Analysis in Patients with Diabetic Chronic Kidney DiseaseJune 15, 2022 | finance.yahoo.comProKidney Announces Manufacturing Efficiency Initiatives and Supply Chain Streamlining Expected to Reduce REACT™ Manufacturing CostsJune 7, 2022 | tmcnet.comObserved Safety Profile Supports Bilateral Dosing of ProKidney's REACT™ - 007 UpdateJune 7, 2022 | finance.yahoo.comObserved Safety Profile Supports Bilateral Dosing of ProKidney’s REACT™ – 007 UpdateMay 20, 2022 | finance.yahoo.comProKidney to present at upcoming investor conferencesMay 3, 2022 | benzinga.comProKidney highlights key registrational program elements supporting advancement of REACT®May 3, 2022 | finance.yahoo.comProKidney highlights key registrational program elements supporting advancement of REACT®April 28, 2022 | tmcnet.comProKidney Appoints Libbie Parker McKenzie, MD, FASN as Chief Medical OfficerSee More Headlines Receive DNAC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Social Capital Suvretta Holdings Corp. III and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryN/A Current SymbolNASDAQ:DNAC CUSIPN/A CIK1850270 WebN/A Phone650-521-9008FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.11 Quick Ratio0.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-28.12Miscellaneous Outstanding Shares25,640,000Free FloatN/AMarket Cap$237.94 million OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Chamath Palihapitiya (Age 45)CEO & Chairman Mr. Kishan Mehta (Age 36)Pres & Director Dr. James Ryans Ph.D. (Age 46)Chief Financial Officer Key CompetitorsKodiak SciencesNASDAQ:KODElevation OncologyNASDAQ:ELEVCardiff OncologyNASDAQ:CRDFX4 PharmaceuticalsNASDAQ:XFORAcumen PharmaceuticalsNASDAQ:ABOSView All Competitors DNAC Stock Analysis - Frequently Asked Questions When did Social Capital Suvretta Holdings Corp. III IPO? Social Capital Suvretta Holdings Corp. III (DNAC) raised $200 million in an IPO on Wednesday, June 30th 2021. The company issued 20,000,000 shares at $10.00 per share. This page (NASDAQ:DNAC) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeUrgent alert: open this for a huge profit potentialTimothy SykesTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBiden out June 13; Kamala won’t replace him?Paradigm PressThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Social Capital Suvretta Holdings Corp. III Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.